Kala Pharmaceuticals Announces FDA Approval of EYSUVIS™ for the Short-Term Treatment of the Signs and Symptoms of Dry Eye Disease by Seini Moimoi | Oct 27, 2020 | Portfolio News
Aptinyx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option by Seini Moimoi | Oct 26, 2020 | Portfolio News
Orbus Therapeutics Expands Series A Financing to $71 Million to Support Ongoing STELLAR Phase 3 Study in Rare Brain Cancer by Seini Moimoi | Oct 22, 2020 | Portfolio News
Akebia Presents Results from its INNO2VATE Global Phase 3 Program; Demonstrated Efficacy and Cardiovascular Safety of Vadadustat for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis by Seini Moimoi | Oct 22, 2020 | Portfolio News
Eargo, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares by Seini Moimoi | Oct 20, 2020 | Portfolio News
